Cargando…
Targeted In Vivo Mutagenesis in Yeast Using CRISPR/Cas9 and Hyperactive Cytidine and Adenine Deaminases
[Image: see text] Directed evolution is a preferred strategy to improve the function of proteins such as enzymes that act as bottlenecks in metabolic pathways. Common directed evolution approaches rely on error-prone PCR-based libraries where the number of possible variants is usually limited by cel...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443040/ https://www.ncbi.nlm.nih.gov/pubmed/37486333 http://dx.doi.org/10.1021/acssynbio.2c00690 |
_version_ | 1785093737099034624 |
---|---|
author | Skrekas, Christos Limeta, Angelo Siewers, Verena David, Florian |
author_facet | Skrekas, Christos Limeta, Angelo Siewers, Verena David, Florian |
author_sort | Skrekas, Christos |
collection | PubMed |
description | [Image: see text] Directed evolution is a preferred strategy to improve the function of proteins such as enzymes that act as bottlenecks in metabolic pathways. Common directed evolution approaches rely on error-prone PCR-based libraries where the number of possible variants is usually limited by cellular transformation efficiencies. Targeted in vivo mutagenesis can advance directed evolution approaches and help to overcome limitations in library generation. In the current study, we aimed to develop a high-efficiency time-controllable targeted mutagenesis toolkit in the yeast Saccharomyces cerevisiae by employing the CRISPR/Cas9 technology. To that end, we fused the dCas9 protein with hyperactive variants of adenine and cytidine deaminases aiming to create an inducible CRISPR-based mutagenesis tool targeting a specific DNA sequence in vivo with extended editing windows and high mutagenesis efficiency. We also investigated the effect of guide RNA multiplexing on the mutagenesis efficiency both phenotypically and on the DNA level. |
format | Online Article Text |
id | pubmed-10443040 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-104430402023-08-23 Targeted In Vivo Mutagenesis in Yeast Using CRISPR/Cas9 and Hyperactive Cytidine and Adenine Deaminases Skrekas, Christos Limeta, Angelo Siewers, Verena David, Florian ACS Synth Biol [Image: see text] Directed evolution is a preferred strategy to improve the function of proteins such as enzymes that act as bottlenecks in metabolic pathways. Common directed evolution approaches rely on error-prone PCR-based libraries where the number of possible variants is usually limited by cellular transformation efficiencies. Targeted in vivo mutagenesis can advance directed evolution approaches and help to overcome limitations in library generation. In the current study, we aimed to develop a high-efficiency time-controllable targeted mutagenesis toolkit in the yeast Saccharomyces cerevisiae by employing the CRISPR/Cas9 technology. To that end, we fused the dCas9 protein with hyperactive variants of adenine and cytidine deaminases aiming to create an inducible CRISPR-based mutagenesis tool targeting a specific DNA sequence in vivo with extended editing windows and high mutagenesis efficiency. We also investigated the effect of guide RNA multiplexing on the mutagenesis efficiency both phenotypically and on the DNA level. American Chemical Society 2023-07-24 /pmc/articles/PMC10443040/ /pubmed/37486333 http://dx.doi.org/10.1021/acssynbio.2c00690 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Skrekas, Christos Limeta, Angelo Siewers, Verena David, Florian Targeted In Vivo Mutagenesis in Yeast Using CRISPR/Cas9 and Hyperactive Cytidine and Adenine Deaminases |
title | Targeted In Vivo Mutagenesis in Yeast
Using CRISPR/Cas9 and Hyperactive Cytidine and Adenine Deaminases |
title_full | Targeted In Vivo Mutagenesis in Yeast
Using CRISPR/Cas9 and Hyperactive Cytidine and Adenine Deaminases |
title_fullStr | Targeted In Vivo Mutagenesis in Yeast
Using CRISPR/Cas9 and Hyperactive Cytidine and Adenine Deaminases |
title_full_unstemmed | Targeted In Vivo Mutagenesis in Yeast
Using CRISPR/Cas9 and Hyperactive Cytidine and Adenine Deaminases |
title_short | Targeted In Vivo Mutagenesis in Yeast
Using CRISPR/Cas9 and Hyperactive Cytidine and Adenine Deaminases |
title_sort | targeted in vivo mutagenesis in yeast
using crispr/cas9 and hyperactive cytidine and adenine deaminases |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443040/ https://www.ncbi.nlm.nih.gov/pubmed/37486333 http://dx.doi.org/10.1021/acssynbio.2c00690 |
work_keys_str_mv | AT skrekaschristos targetedinvivomutagenesisinyeastusingcrisprcas9andhyperactivecytidineandadeninedeaminases AT limetaangelo targetedinvivomutagenesisinyeastusingcrisprcas9andhyperactivecytidineandadeninedeaminases AT siewersverena targetedinvivomutagenesisinyeastusingcrisprcas9andhyperactivecytidineandadeninedeaminases AT davidflorian targetedinvivomutagenesisinyeastusingcrisprcas9andhyperactivecytidineandadeninedeaminases |